Compare GENC & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GENC | QSI |
|---|---|---|
| Founded | N/A | 2013 |
| Country | United States | United States |
| Employees | 318 | 145 |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 210.0M | 194.8M |
| IPO Year | 1995 | N/A |
| Metric | GENC | QSI |
|---|---|---|
| Price | $14.54 | $0.84 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $17.60 | $1.00 |
| AVG Volume (30 Days) | 15.5K | ★ 6.1M |
| Earning Date | 02-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8.08 | N/A |
| EPS | ★ 0.23 | N/A |
| Revenue | ★ $48,943,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $25.51 | $618.07 |
| P/E Ratio | $62.70 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.22 | $0.69 |
| 52 Week High | $17.40 | $3.10 |
| Indicator | GENC | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 46.15 | 43.22 |
| Support Level | $13.82 | $0.69 |
| Resistance Level | $14.59 | $1.08 |
| Average True Range (ATR) | 0.52 | 0.07 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 23.49 | 13.98 |
Gencor Industries Inc and its subsidiaries are a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company's products are manufactured in the United States and sold through a combination of Company sales representatives and independent dealers and agents. The Company has one reporting segment, equipment for the highway construction industry. The Company's principal core products include asphalt pavers, hot mix asphalt plants, combustion systems, and fluid heat transfer systems. It operates in the United States, Canada, and other foreign countries, with the majority of revenue coming from the United States.
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.